Oxford Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Oxford Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,608	Closed	-$482K	–	2064
2019 Q2	$482K	Buy	+9,608	New	+$468K	0.01%	1293
2017 Q4	–	Sell	-81,650	Closed	-$3.47M	–	1949
2017 Q3	$3.47M	Sell	81,650 -52,458	-39%	-$1.67M	0.07%	350
2017 Q2	$1.76M	Buy	+134,108	New	+$1.77M	0.04%	664

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Oxford Asset Management's MYOK Position: Q3 2019 in Review

Oxford Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 9,608 shares — an estimated $482K sold.

Oxford Asset Management first reported a position in MYOK in Q2 2017 and held it in 3 quarters. The position peaked at $3.47M in Q3 2017. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

Oxford Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 9,608 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $482K.
Oxford Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Oxford Asset Management's MyoKardia, Inc. Common Stock position peaked at $3.47M in Q3 2017.
157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.